PD-L1 Expression in Japanese Renal Cell Carcinoma Patients

Clinical trial NCT03748901 · COMPLETED

Trial details

NCT number: NCT03748901
Sponsor: Chugai Pharmaceutical
Status: COMPLETED
Study type: OBSERVATIONAL

Renal Cell Carcinoma

Start date: 2018-12-16
Primary completion: 2021-07-21
Enrollment: 830

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.